Sfoglia per Autore
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.
2009 Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccarani M; Martelli AM; Manzoli L; Martinelli G; Cocco L
PKR Activity Is Required for Acute Leukemic Cell Maintenance and Growth: A Role for PKR-Mediated Phosphatase Activity to Regulate GSK-3 Phosphorylation.
2009 W.L. Blalock; C. Grimaldi; F. Falà; M. Follo; S. Horn; J. Basecke; G. Martinelli; L. Cocco; A.M. Martelli.
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients.
2009 Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco
Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology.
2009 Cocco L; Faenza I; Follo MY; Billi AM; Ramazzotti G; Papa V; Martelli AM; Manzoli L
Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
2009 Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L.
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study
2010 Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo
Nuclear inositide signaling in myelodysplastic syndromes.
2010 Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment
2010 Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco
Inositide signaling in the nucleus: From physiology to pathology.
2010 Cocco L; Follo MY; Faenza I; Billi AM; Ramazzotti G; Martelli AM; Manzoli L; Weber G.
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response
2011 C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients
2011 Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients
2011 Matilde Y. Follo; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Michele Baccarani; Giovanni Martinelli; Patrizia Santi; Giulia Ramazzotti; Anna Maria Billi; Lucia Manzoli; Carlo Finelli; Lucio Cocco
Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study
2011 C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A. Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo
PROLONGED HEMATOLOGIC AND MOLECULAR RESPONSE AFTER A LIMITED NUMBER OF AZACITIDINE CYCLES IN LOW-RISK MYELODYSPLASTIC SYNDROMES
2011 C Finelli;C Clissa; M Follo; D Russo; C Filì; A Curti;S Paolini; C Bosi; S Mongiorgi; L Manzoli; C Papayannidis; S Parisi; G Martinelli; L Cocco; M Baccarani
Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy
2011 M.Y. Follo; S. Mongiorgi; C. Clissa; C. Bosi; M. Baccarani; G. Martinelli; L. Manzoli; C. Finelli; L. Cocco
EFFECT OF LENALIDOMIDE ON INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS
2011 Follo MY;Mongiorgi S; Clissa C; Baccarani M; Paolini S; Martinelli G; Manzoli L; Finelli C; Cocco L
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES
2011 Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M
The physiology and pathology of inositide signaling in the nucleus
2011 Ramazzotti G.; Faenza I.; Fiume R.; Matteucci A.; Piazzi M.; Follo MY.; Cocco L.
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients
2011 M.Y. Follo; S. Mongiorgi; C. Clissa; C. Filì; C. Colombi; M. Baccarani; G. Martinelli; M. Gobbi; L. Manzoli; D. Russo; C. Finelli; L. Cocco
Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress
2011 Blalock WL; Bavelloni A; Piazzi M; Tagliavini F; Faenza I; Martelli AM; Follo MY; Cocco L
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. |
Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccara...ni M; Martelli AM; Manzoli L; Martinelli G; Cocco L |
2009-01-01 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - | 1.01 Articolo in rivista | - |
| PKR Activity Is Required for Acute Leukemic Cell Maintenance and Growth: A Role for PKR-Mediated Phosphatase Activity to Regulate GSK-3 Phosphorylation. | W.L. Blalock; C. Grimaldi; F. Falà; M. Follo; S. Horn; J. Basecke; G. Martinelli; L. Cocco; A.M. ...Martelli. | 2009-01-01 | JOURNAL OF CELLULAR PHYSIOLOGY | - | 1.01 Articolo in rivista | - |
| Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele B...accarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco | 2009-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. |
Cocco L; Faenza I; Follo MY; Billi AM; Ramazzotti G; Papa V; Martelli AM; Manzoli L |
2009-01-01 | - | ELSEVIER | 2.01 Capitolo / saggio in libro | - |
| Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia. | Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martell...i AM; Cocco L. | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study | Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani...; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo | 2010-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Nuclear inositide signaling in myelodysplastic syndromes. | Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli ...AM; Cocco L | 2010-01-01 | JOURNAL OF CELLULAR BIOCHEMISTRY | - | 1.01 Articolo in rivista | - |
| Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; ...Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco | 2010-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Inositide signaling in the nucleus: From physiology to pathology. | Cocco L; Follo MY; Faenza I; Billi AM; Ramazzotti G; Martelli AM; Manzoli L; Weber G. | 2010-01-01 | - | Elsevier | 2.01 Capitolo / saggio in libro | - |
| Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response | C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; ...L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients | Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni... Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco | 2011-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients | Matilde Y. Follo; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Michele Baccarani; Giovanni Mar...tinelli; Patrizia Santi; Giulia Ramazzotti; Anna Maria Billi; Lucia Manzoli; Carlo Finelli; Lucio Cocco | 2011-01-01 | ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY | - | 4.01 Contributo in Atti di convegno | - |
| Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study | C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A.... Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| PROLONGED HEMATOLOGIC AND MOLECULAR RESPONSE AFTER A LIMITED NUMBER OF AZACITIDINE CYCLES IN LOW-RISK MYELODYSPLASTIC SYNDROMES |
C Finelli;C Clissa; M Follo; D Russo; C Filì; A Curti;S Paolini; C Bosi; S Mongiorgi; L Manzoli;... C Papayannidis; S Parisi; G Martinelli; L Cocco; M Baccarani |
2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy | M.Y. Follo; S. Mongiorgi; C. Clissa; C. Bosi; M. Baccarani; G. Martinelli; L. Manzoli; C. Finelli...; L. Cocco | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.01 Contributo in Atti di convegno | - |
| EFFECT OF LENALIDOMIDE ON INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS |
Follo MY;Mongiorgi S; Clissa C; Baccarani M; Paolini S; Martinelli G; Manzoli L; Finelli C; Cocco L |
2011-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
| AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES |
Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; ...Manzoli L; Martinelli G; Cocco L; Baccarani M |
2011-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
| The physiology and pathology of inositide signaling in the nucleus | Ramazzotti G.; Faenza I.; Fiume R.; Matteucci A.; Piazzi M.; Follo MY.; Cocco L. | 2011-01-01 | JOURNAL OF CELLULAR PHYSIOLOGY | - | 1.01 Articolo in rivista | - |
| Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients | M.Y. Follo; S. Mongiorgi; C. Clissa; C. Filì; C. Colombi; M. Baccarani; G. Martinelli; M. Gobbi; ...L. Manzoli; D. Russo; C. Finelli; L. Cocco | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.01 Contributo in Atti di convegno | - |
| Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress | Blalock WL; Bavelloni A; Piazzi M; Tagliavini F; Faenza I; Martelli AM; Follo MY; Cocco L | 2011-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile